Website University of Alabama at Birmingham
Multiple fully funded postdoctoral fellowships are available in the laboratories of Dr. Karen Gamble and Dr. Erik Roberson to study circadian disruption in Alzheimer’s disease (one position in each laboratory). Both positions are focused on the basis of circadian variation in AD-related hyperexcitability and interneuron dysfunction. Both labs are funded by the NIH, and the Roberson lab has additional funding from the Bluefield Project to Cure FTD and the Alzheimer’s Drug Discovery Foundation.
Candidates must possess a Ph.D. or equivalent degree and should be highly motivated, creative, and productive, with excellent oral and written communication skills and a strong publication record. Experience with mouse models is important, and expertise with chemogenetics/optogenetics, in vivo assessment of neuronal activity, such as EEG, is particularly desirable.
Please send your CV and statement of research interests to Dr. Gamble (klgamble@uab.edu) or Dr. Roberson (eroberson@uabmc.edu). The names of three references would be helpful, but references will not be contacted until after initial discussions with the candidate.
UAB:
The University of Alabama at Birmingham is ranked in the top 10 among public universities for NIH funding. A broad and collegial environment for neuroscience research is facilitated by the UAB Comprehensive Neuroscience Center, a network of over 200 basic, translational and clinical faculty from 23 departments. Neurodegeneration is a particular strength spanning both basic and clinic research.
UAB is an Equal Opportunity/Affirmative Action Employer committed to fostering a diverse, equitable and family-friendly environment in which all faculty and staff can excel and achieve work/life balance irrespective of ethnicity, gender, faith, gender identity and expression as well as sexual orientation. UAB also encourages applications from individuals with disabilities and veterans.
Comments are closed.